
The DPP-4 inhibitor linagliptin and the GLP-1 receptor agonist exendin-4 improve endothelium-dependent relaxation of rat mesenteric arteries in the presence of high glucose
Keywords: DPP-4, dipeptidyl peptidase-4; DPI, diphenyliodonium; eNOS, endothelial nitric oxide synthase; EDHF, endothelium-dependent hyperpolarization Factor; GIP, glucose-dependent insulinotropic polypeptide; GLP-1R, glucagon-like peptide-1 receptor; IKCa, interme